This ex vivo data generated with patient-derived metastatic breast tumor tissue confirms results obtained from BC cell lines, suggesting that activation of a senescence program induced by increased expression of p16INK4a is one mechanism by which NS1643 inhibits tumor growth. This evidence concerns the gene CDKN2A and breast cancer.